Senior NGS Scientist - Single-Cell & Target Discovery

Globalchannelmanagement; Boston (MA); On-site; USD 90,000 - 130,000; Full time

Job summary

Globalchannelmanagement is seeking a Senior Research Associate – Next-Generation Sequencing (NGS) with 3–5 years of bench experience. You will lead RNA-seq, bulk and single-cell sequencing workflows, and contribute to target identification and data QC.

The role requires strong molecular biology skills, expertise in nucleic acid extraction, qPCR, and NGS library prep/QC, with hands-on experience on Illumina platforms and multiple scRNA-seq/single-cell platforms.

Qualifications

• BS and/or MS in biological or biochemical sciences with 3–5 years of hands-on lab research.
• Experience with nucleic acid extraction, purification, quantification, and NGS library prep/QC.
• Excellent documentation and time-management using electronic lab notebooks.

Responsibilities

• Lead RNA-seq, bulk, amplicon, and single-cell sequencing workflows.
• Design and execute molecular biology experiments to identify and validate targets.
• Support assay design, optimization, validation, and QC.
• Troubleshoot complex data anomalies to keep projects moving forward.
• Translate results into oral presentations and written documentation.
• Document experiments in electronic notebook software; maintain meticulous records.
• Collaborate across teams to ensure project alignment and timely reporting.

Skills

RNA-seq

scRNA-seq

Bulk RNA-seq

qPCR

Data QC

Education

BS/MS in biology

Tools

Illumina

10X Genomics

PIP-seq

ScaleBio

Parse Biosciences

Mantis

Job description

Globalchannelmanagement is seeking a Senior Research Associate – Next-Generation Sequencing (NGS) with 3–5 years of bench experience. You will lead RNA-seq, bulk and single-cell sequencing workflows, and contribute to target identification and data QC.

The role requires strong molecular biology skills, expertise in nucleic acid extraction, qPCR, and NGS library prep/QC, with hands-on experience on Illumina platforms and multiple scRNA-seq/single-cell platforms.